Searchable abstracts of presentations at key conferences in endocrinology

ea0082p41 | Poster Presentations | SFEEU2022

An interesting cause of Hypertensive Crisis: Phaeochromocytoma

Tulsi Dooshyant , Rao Komal , Bradley Meg , Bawlchhim Zosanglura , Falinska Agnieszka , Russell-Jones David

Case History: A 46 year old lady presented to A&E with a 4 day history of headache, vomiting, abdominal pain and fever. On further questioning, she admitted to having had experienced occasional episodes of palpitations, hot flushes and headaches over the past few months. She had history of appendectomy when she was young and acoustic neuroma removal few years ago. She wasn’t on any regular medications. On clinical examination, she looked visibly unwell and was hypoxic...

ea0090p574 | Calcium and Bone | ECE2023

A long and challenging journey from the first non-typical gastrointestinal manifestations to the diagnosis of primary hyperparathyroidism and MEN 1

Kiluk Małgorzata , Łebkowska Agnieszka , Kowalska Irina , Karczewska-Kupczewska Monika

Introduction: Primary hyperparathyroidism (PHPT), as a state of chronic hypercalcemia, can be manifested by non-typical symptoms which can delay the proper diagnosis for many years and lead to serious preventable complications affecting the patient’s quality of life.Case report: A 52-year-old woman with hypertension, thyroid nodular goiter treated with radioactive iodine and a 20-year history of gastric and duodenal ulcerative disease, complicated b...

ea0090p163 | Pituitary and Neuroendocrinology | ECE2023

Pituitary apoplexy as the first manifestation of non-functioning pituitary neuroendocrine tumor

Dzialach Lukasz , Sobolewska Joanna , Respondek Wioleta , Wojciechowska-Luzniak Agnieszka , Witek Przemysław

Introduction: Pituitary apoplexy (PA) is a rare but potentially life-threatening complication that may occur in pituitary neuroendocrine tumors (PitNETs). Non-functioning PitNETs (NF-PitNETs), specifically macroadenomas, seem to have a higher risk of apoplexy. Case description: A 45-year-old male presented to the emergency unit with a one-week history of binocular visual deterioration (blurred vision, diplopia, visual field defect) with left-side predomi...

ea0090p464 | Reproductive and Developmental Endocrinology | ECE2023

Visfatin expression and regulation by E2, P4, hCG and insulin in human placental cells

Dawid Monika , Kurowska Patrycja , Pawlicki Piotr , Kotula-Balak Małgorzata , Milewicz Tomasz , Rak Agnieszka

Introduction: Visfatin belongs to adipokines, i.e. hormones produced mainly by adipose tissue; its expression and role have been described in many organs, where it regulates energy metabolism, insulin resistance and inflammatory reactions. Moreover, the level of visfatin changes during pregnancy and in obese women and those with obesity related pregnancy pathologies: preeclampsia (PE), gestational diabetes (GDM) or intrauterine growth restriction (IUGR) its level increases. Th...

ea0090ep68 | Adrenal and Cardiovascular Endocrinology | ECE2023

Health state utility value of Cushing syndrome patients after bilateral adrenalectomy–systematic literature review and mapping to EQ-5D

Schmidt Fabian , Pedroncelli Alberto , Marks Muriel , Szewczuk Dominik , Kalinowska Agnieszka , Binowski Grzegorz

Background: Bilateral adrenalectomy (BLA) is a treatment option for patients suffering from endogenous Cushing syndrome (CS). It consists of the surgical removal of both adrenal glands. Even though BLA offers immediate control of cortisol excess, given the risk of adrenal insufficiency, it requires life-long glucocorticoid and mineral corticoid replacement. It may lead to perioperative and long-term complications which affect patients’ quality of life (QoL). Health state ...

ea0090ep719 | Pituitary and Neuroendocrinology | ECE2023

Polyuria after steroid replacement in a patient with adrenal insufficiency – not always vasopressin deficiency

Narula Kavita , Nyunt Sandhi , Sharma Aditi , Lazarus Kate , Falinska Agnieszka , Russell-Jones David , Meeran Karim

A 54-year-old man with a recurrent non-functioning pituitary gonadotroph adenoma previously treated with transphenoidal surgery (TSS) in 2015, presented to Charing Cross hospital for repeat transsphenoidal surgery in May 2022. Since his initial surgery, he remained on Levothyroxine 50 μg once daily only. There was no evidence of adrenal insufficiency (0900 h cortisol 333 nmol/l at day 6 following initial TSS). In February 2022, his electrolytes, FSH, LH, testosterone, pro...

ea0090ep865 | Pituitary and Neuroendocrinology | ECE2023

Asprosin, a novel adipokine, in the mouse hypothalamus: expression and in vitro effect on GT1-7 cells proliferation and GnRH secretion. Preliminary data

Wachowska Dominika , Respekta Natalia , Kurowska Patrycja , Błasiak Anna , Dupont Joelle , Rak Agnieszka

Introduction: Asprosin, a novel adipokine, is a circulating hormone mainly secreted by white adipose tissue. Asprosin is encoded by the penultimate 2 exons of the fibrillin 1 (FBN1) gene. Protein product of FBN1 is profibrillin-1, which undergoes a proteolytic cleavage by furin enzyme to produce mature fibrillin-1 and asprosin. Literature data indicated that asprosin is involved in the development of diabetes, obesity, cardiomyopathy, cancer, and polycystic o...

ea0090ep1144 | Late Breaking | ECE2023

Ectopic ACTH Syndrome in a Patient with ACTH-secreting Pancreatic Neuroendocrine Neoplasm and Focal Pituitary Lesion-Diagnostic Challenges

Sobolewska Joanna , Dzialach Lukasz , Respondek Wioleta , Wojciechowska-Luzniak Agnieszka , Witek Przemysław

Introduction: Pancreatic neuroendocrine neoplasms (Pan-NENs) account for 1-2% of all pancreatic tumors. Adrenocorticotropic hormone (ACTH)-producing PanNEN is an extremely rare neuroendocrine tumor that accounts for approximately 4-16% of ectopic ACTH-dependent Cushing’s syndrome.Clinical case : A 58-year-old female with arterial hypertension and type 2 diabetes was referred to the Endocrinology Department due to abdominal pain, muscle weakness, and...

ea0065p254 | Metabolism and Obesity | SFEBES2019

St James’s Hospital intensive care unit insulin discharge policy – A quality improvement project

Quinn Mark , Courtney Ashling , Smyth Coilin-Collins , Healy Marie-Louise , Pazderska Agnieszka , O'Connor Enda

Background: Many patients require IV insulin during their critical illness. Maintenance of insulin in St James’s Hospital ICU is governed by a local protocol. At the time of ICU discharge, IV insulin therapy is often stopped. Transitioning from IV to subcutaneous insulin is often done with endocrinology input. If this is unavailable inappropriate insulin dosing may increase the risk of hypo-/hyperglycaemia.Aims: To reduce the number of episodes of h...

ea0067gp17 | Poster Presentations | EYES2019

Etomidate as a treatment option in severe ACTH-dependent (ectopic) Cushing syndrome

Nowak Karolina M , Łebek-Szatańska Agnieszka , Papierska Lucyna

Background: Etomidate is mainly used in general anesthesia. In some rare cases it can also be helpful in treating life-thretening severe hypercortisolaemia (in much lower doses) in patients who are not able to take oral medications or when oral drugs are not available.Case Presentation: Fifty-seven-year-old woman with symptoms of virilization, hypokalemia and muscle weekness for 6 months was admitted to Department of Endocrinology. On admission cortisol ...